What does evidence show about smoking, psoriasis onset and severity?

01

Occurrence, flares and response are three questions

A 2026 synthesis still found a positive association between smoking and psoriasis occurrence, with substantial differences across studies. Its cessation and subtype analyses were limited or exploratory. It does not convert an occurrence association into a promise that stopping will resolve an existing flare.

New psoriasis, prevalence, plaque severity, flare frequency, joint involvement and treatment response are distinct endpoints.

[3][2]

02

Why similar results need not have the same explanation

Inflammatory and immune pathways make an association plausible, but no mechanism distinguishes psoriasis from eczema, infection or another rash online.

Smoking definition, reverse causation, alcohol, body composition, stress and treatment selection can shape observational estimates.

[1]

03

What “poorer response” actually referred to

The 2020 meta-analysis examined occurrence studies separately from treatment studies. Its pooled six-month response comparison concerned biologic treatment and ever-smokers versus nonsmokers. It did not test whether stopping smoking changes an individual flare. “Ever” also combines people who still smoke with those who previously stopped. Before using a treatment headline, check which treatment, time point and response definition were studied; a skin-severity finding cannot substitute for that comparison.

[1]

04

Bring the outcome question to a dermatologist

Ask whether the evidence concerns developing psoriasis, its course, or a particular treatment response. A dermatologist can place that distinction alongside your own care. General tobacco resources are for smoking support; they do not choose psoriasis treatment. No image assessment or medicine change follows from this page.

[2]